Cancer patients who received mRNA-based COVID vaccines within 100 days of starting treatment with widely used immunotherapies ...

The researchers found that mRNA-based COVID-19 vaccines could potentially help patients whose tumors don’t respond well to ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up ...

Cancer patients who received the mRNA-based jab after starting immunotherapy lived significantly longer than those who did ...

People with advanced skin and lung cancers who received mRNA Covid-19 vaccines within 100 days of starting immunotherapy ...

Researchers at UF Health and the University of Texas MD Anderson have found that cancer patients may live longer if they ...

RNA vaccines seem to boost the effectiveness of an immune therapy for skin and lung cancer ― in an unexpected way.

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice ...

A new study from MD Anderson Cancer Center shows cancer patients who received mRNA-based COVID vaccines within 100 days of ...

A study published in Nature looks at COVID-19 mRNA vaccines and the immune response to tumours during immunotherapy. Prof Andrew Beggs, MRC Senior Clinical Fellow and Consultant Colorectal Surgeon, ...

A new study suggests that mRNA vaccines for COVID-19 could help boost the effects of immunotherapy drugs for some cancer patients.

NEW YORK – BioNTech said Wednesday that it began an exchange offer to complete its $1.25B all-stock acquisition of mRNA immunotherapy developer CureVac, a deal that was announced in June.